next_plan

US Supreme Court Human Genome Patents (Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 June 13, 2013 & now in Congress, the 'Patent Eligibility Restoration Act' of 2022/2023) to overturn patenting DNA decision

expand_more
1 views1 year ago
thumb_downDislike
library_addSave
flagReport
Comments0
unfold_more